Article
Napa, CA-Santen Inc. has promoted two former product directors to its executive team.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
PainReform acquires majority equity interest in LayerBio
3 Things You Should Know About Interventional Glaucoma Comanagement
Seeing the unseen: Improving early detection for patients with MacTel
Patient-Centered Treatment Strategies in the Management of nAMD and DME
REGENXBIO launches phase 2b/3 trial of sura-vec for diabetic retinopathy
Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs